Evidence map›Paper›PMID 32796213›Full record

ArticleAIDS (London, England)2020

Using HIV self-testing to increase the affordability of community-based HIV testing services.

Marc d'Elbée, Molemo Charles Makhetha, Makhahliso Jubilee, Matee Taole, Cyril Nkomo, Albert Machinda, Mphotleng Tlhomola, Linda A Sande, Gabriela B Gomez Guillen, Elizabeth L Corbett and 4 more

Abstract read
In one paragraph

Article in AIDS (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marc d'ElbéeDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Molemo Charles MakhethaPopulation Services International, Maseru, Lesotho.
Makhahliso JubileeJohn Snow Inc., Lusaka, Zambia.
Matee TaolePopulation Services International, Maseru, Lesotho.
Cyril NkomoPopulation Services International, Maseru, Lesotho.
Albert MachindaPopulation Services International, Maseru, Lesotho.
Mphotleng TlhomolaMinistry of Health, Maseru, Lesotho.
Linda A SandeDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Gabriela B Gomez GuillenDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Elizabeth L CorbettMalawi Liverpool Wellcome Trust Research Programme, Blantyre, Malawi.
Cheryl C JohnsonWorld Health Organisation, Global HIV, Hepatitis and STI Programme, Geneva, Switzerland.
Karin HatzoldPopulation Services International.
Gesine Meyer-RathHealth Economics and Epidemiology Research Office (HERO), Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Fern Terris-PrestholtDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Wellcome Trust 200901/Z/16/ZWellcome Trust WT200901/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

objectivesThis study estimates the costs of community-based HIV testing services (HTS) in Lesotho and assesses the potential efficiency gains achieved by adding HIV self-testing (HIVST) and then self-testing booths.

designMicro-costing analysis using longitudinal data from a real-world intervention.

methodsWe collected data prospectively on provider's costs and programmatic outcomes over three time periods of approximately 8 months each, between May 2017 and April 2019. The scope of services was extended during each period as follows: HTS only, HTS and HIVST, HTS and HIVST with individual HIVST booths wherein clients were encouraged to self-test on-site followed by on-site confirmative testing for those with reactive self-test. For each implementation period, we estimated the full financial and economic implementation costs, the incremental costs of adding HIVST onto conventional HTS and the cost per HIV positive case identified.

resultsCosts per HIV-positive case identified increased between period 1 (US$956) and period 2 (US$1249) then dropped in period 3 (US$813). Full versus incremental cost analyses resulted in large differences in the magnitude of costs, attributable to methods rather than resource use: for example, in period 3, the average full and incremental cost estimates for HTS were US$34.3 and US$23.5 per person tested, and for HIVST were US$37.7 and US$14.0 per kit provided, respectively.

conclusionIn Lesotho, adding HIVST to community-based HTS improves its overall affordability for HIV-positive case finding. The reporting of both full and incremental cost estimates increase transparency for use in priority setting, budgeting and financial planning for scale-up.

Indexed as

Self-TestingCommunity-Based Participatory ResearchCommunity Health ServicesCosts and Cost AnalysisHIV InfectionsHIV TestingHumansLesothoMass Screening

Identifiers

PMID32796213
PMCPMC8425631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.